| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T0 |
7-12 |
GENE |
denotes |
FGF21 |
| T1 |
7-12 |
GENE |
denotes |
FGF21 |
| T2 |
13-19 |
MPA |
denotes |
levels |
| T3 |
23-28 |
DISEASE |
denotes |
obese |
| T4 |
76-85 |
DISEASE |
denotes |
bariatric |
| T5 |
97-103 |
MPA |
denotes |
marker |
| T6 |
107-116 |
CPA |
denotes |
metabolic |
| T7 |
117-123 |
CPA |
denotes |
stress |
| T8 |
136-163 |
GENE |
denotes |
Fibroblast growth factor 2 |
| T9 |
137-164 |
GENE |
denotes |
Fibroblast growth factor 21 |
| T10 |
165-170 |
GENE |
denotes |
(FGF2 |
| T11 |
166-171 |
GENE |
denotes |
FGF21 |
| T12 |
201-217 |
MPA |
denotes |
endocrine signal |
| T13 |
221-239 |
CPA |
denotes |
nutritional status |
| T14 |
247-253 |
REG |
denotes |
active |
| T15 |
254-263 |
MPA |
denotes |
regulator |
| T16 |
267-277 |
CPA |
denotes |
metabolism |
| T17 |
317-323 |
REG |
denotes |
effect |
| T18 |
326-337 |
DISEASE |
denotes |
weight-los |
| T19 |
327-348 |
CPA |
denotes |
weight-loss therapies |
| T20 |
364-370 |
MPA |
denotes |
levels |
| T21 |
373-378 |
GENE |
denotes |
FGF2 |
| T22 |
374-379 |
GENE |
denotes |
FGF21 |
| T23 |
410-415 |
GENE |
denotes |
s FGF |
| T24 |
412-417 |
GENE |
denotes |
FGF21 |
| T25 |
430-436 |
MPA |
denotes |
levels |
| T26 |
440-449 |
DISEASE |
denotes |
adiposity |
| T27 |
450-456 |
DISEASE |
denotes |
excess |
| T28 |
475-486 |
DISEASE |
denotes |
t weight-lo |
| T29 |
500-510 |
REG |
denotes |
prescribed |
| T30 |
589-605 |
CPA |
denotes |
Body composition |
| T31 |
604-611 |
DISEASE |
denotes |
n, keto |
| T32 |
607-614 |
CPA |
denotes |
ketosis |
| T33 |
616-635 |
CPA |
denotes |
insulin sensitivity |
| T34 |
637-642 |
GENE |
denotes |
nd FG |
| T35 |
640-645 |
GENE |
denotes |
FGF21 |
| T36 |
651-660 |
REG |
denotes |
evaluated |
| T37 |
668-674 |
DISEASE |
denotes |
excess |
| T38 |
727-733 |
DISEASE |
denotes |
excess |
| T39 |
832-841 |
REG |
denotes |
undertook |
| T40 |
898-906 |
REG |
denotes |
followed |
| T41 |
959-968 |
REG |
denotes |
underwent |
| T42 |
969-978 |
DISEASE |
denotes |
bariatric |
| T43 |
1100-1104 |
GENE |
denotes |
S: F |
| T44 |
1103-1108 |
GENE |
denotes |
FGF21 |
| T45 |
1109-1115 |
MPA |
denotes |
levels |
| T46 |
1121-1127 |
POSREG |
denotes |
higher |
| T47 |
1131-1137 |
DISEASE |
denotes |
excess |
| T48 |
1225-1229 |
NEGREG |
denotes |
lose |
| T49 |
1237-1244 |
REG |
denotes |
induced |
| T50 |
1259-1267 |
NEGREG |
denotes |
decrease |
| T51 |
1310-1316 |
MPA |
denotes |
levels |
| T52 |
1316-1321 |
GENE |
denotes |
of F |
| T53 |
1320-1325 |
GENE |
denotes |
FGF21 |
| T54 |
1424-1429 |
GENE |
denotes |
in F |
| T55 |
1428-1433 |
GENE |
denotes |
FGF21 |
| T56 |
1434-1440 |
MPA |
denotes |
levels |
| T57 |
1508-1517 |
DISEASE |
denotes |
bariatric |
| T58 |
1531-1536 |
DISEASE |
denotes |
dly o |
| T59 |
1535-1540 |
DISEASE |
denotes |
obese |
| T60 |
1550-1556 |
REG |
denotes |
showed |
| T61 |
1571-1579 |
POSREG |
denotes |
increase |
| T62 |
1579-1584 |
GENE |
denotes |
in F |
| T63 |
1583-1588 |
GENE |
denotes |
FGF21 |
| T64 |
1640-1646 |
POSREG |
denotes |
higher |
| T65 |
1663-1668 |
GENE |
denotes |
The F |
| T66 |
1667-1672 |
GENE |
denotes |
FGF21 |
| T67 |
1686-1693 |
REG |
denotes |
changes |
| T68 |
1694-1699 |
REG |
denotes |
occur |
| T69 |
1729-1736 |
DISEASE |
denotes |
ced ket |
| T70 |
1733-1740 |
CPA |
denotes |
ketosis |
| T71 |
1741-1750 |
REG |
denotes |
situation |
| T72 |
1769-1778 |
DISEASE |
denotes |
bariatric |
| T73 |
1795-1806 |
POSREG |
denotes |
improvement |
| T74 |
1810-1819 |
DISEASE |
denotes |
adiposity |
| T75 |
1832-1843 |
CPA |
denotes |
sensitivity |
| T76 |
1844-1851 |
REG |
denotes |
induced |
| T77 |
1886-1890 |
GENE |
denotes |
S: F |
| T78 |
1889-1894 |
GENE |
denotes |
FGF21 |
| T79 |
1895-1901 |
MPA |
denotes |
levels |
| T80 |
1907-1914 |
NEGREG |
denotes |
reduced |
| T81 |
1921-1949 |
MPA |
denotes |
energy-restricted treatments |
| T82 |
1963-1972 |
POSREG |
denotes |
increased |
| T83 |
1979-1988 |
DISEASE |
denotes |
bariatric |
| T84 |
2026-2035 |
NEGREG |
denotes |
reduction |
| T85 |
2055-2066 |
CPA |
denotes |
sensitivity |
| T86 |
2066-2073 |
DISEASE |
denotes |
or ket |
| T87 |
2070-2077 |
CPA |
denotes |
ketosis |
| T88 |
2086-2091 |
GENE |
denotes |
re, F |
| T89 |
2090-2095 |
GENE |
denotes |
FGF21 |
| T90 |
2112-2118 |
MPA |
denotes |
marker |
| T91 |
2129-2140 |
CPA |
denotes |
nutritional |
| T92 |
2141-2147 |
CPA |
denotes |
stress |
| R0 |
T0 |
T2 |
ThemeOf |
FGF21,levels |
| R1 |
T0 |
T5 |
ThemeOf |
FGF21,marker |
| R2 |
T3 |
T2 |
ThemeOf |
obese,levels |
| R3 |
T3 |
T5 |
ThemeOf |
obese,marker |
| R4 |
T3 |
T7 |
ThemeOf |
obese,stress |
| R5 |
T3 |
T14 |
ThemeOf |
obese,active |
| R6 |
T4 |
T5 |
ThemeOf |
bariatric,marker |
| R7 |
T4 |
T7 |
ThemeOf |
bariatric,stress |
| R8 |
T6 |
T5 |
ThemeOf |
metabolic,marker |
| R9 |
T5 |
T7 |
ThemeOf |
marker,stress |
| R10 |
T5 |
T14 |
ThemeOf |
marker,active |
| R11 |
T6 |
T7 |
ThemeOf |
metabolic,stress |
| R12 |
T6 |
T14 |
ThemeOf |
metabolic,active |
| R13 |
T9 |
T5 |
ThemeOf |
Fibroblast growth factor 21,marker |
| R14 |
T9 |
T7 |
ThemeOf |
Fibroblast growth factor 21,stress |
| R15 |
T9 |
T12 |
ThemeOf |
Fibroblast growth factor 21,endocrine signal |
| R16 |
T9 |
T14 |
ThemeOf |
Fibroblast growth factor 21,active |
| R17 |
T9 |
T15 |
ThemeOf |
Fibroblast growth factor 21,regulator |
| R18 |
T11 |
T5 |
ThemeOf |
FGF21,marker |
| R19 |
T11 |
T6 |
ThemeOf |
FGF21,metabolic |
| R20 |
T11 |
T7 |
ThemeOf |
FGF21,stress |
| R21 |
T11 |
T12 |
ThemeOf |
FGF21,endocrine signal |
| R22 |
T11 |
T14 |
ThemeOf |
FGF21,active |
| R23 |
T11 |
T15 |
ThemeOf |
FGF21,regulator |
| R24 |
T13 |
T12 |
ThemeOf |
nutritional status,endocrine signal |
| R25 |
T12 |
T14 |
ThemeOf |
endocrine signal,active |
| R26 |
T12 |
T15 |
ThemeOf |
endocrine signal,regulator |
| R27 |
T13 |
T14 |
ThemeOf |
nutritional status,active |
| R28 |
T13 |
T15 |
ThemeOf |
nutritional status,regulator |
| R29 |
T15 |
T14 |
ThemeOf |
regulator,active |
| R30 |
T16 |
T15 |
ThemeOf |
metabolism,regulator |
| R31 |
T16 |
T7 |
ThemeOf |
metabolism,stress |
| R32 |
T16 |
T12 |
ThemeOf |
metabolism,endocrine signal |
| R33 |
T16 |
T14 |
ThemeOf |
metabolism,active |
| R34 |
T19 |
T17 |
ThemeOf |
weight-loss therapies,effect |
| R35 |
T20 |
T19 |
ThemeOf |
levels,weight-loss therapies |
| R36 |
T20 |
T17 |
ThemeOf |
levels,effect |
| R37 |
T22 |
T17 |
ThemeOf |
FGF21,effect |
| R38 |
T22 |
T19 |
ThemeOf |
FGF21,weight-loss therapies |
| R39 |
T22 |
T20 |
ThemeOf |
FGF21,levels |
| R40 |
T24 |
T25 |
ThemeOf |
FGF21,levels |
| R41 |
T24 |
T29 |
ThemeOf |
FGF21,prescribed |
| R42 |
T27 |
T25 |
ThemeOf |
excess,levels |
| R43 |
T25 |
T29 |
ThemeOf |
levels,prescribed |
| R44 |
T26 |
T25 |
ThemeOf |
adiposity,levels |
| R45 |
T26 |
T27 |
ThemeOf |
adiposity,excess |
| R46 |
T26 |
T29 |
ThemeOf |
adiposity,prescribed |
| R47 |
T27 |
T29 |
ThemeOf |
excess,prescribed |
| R48 |
T30 |
T36 |
ThemeOf |
Body composition,evaluated |
| R49 |
T32 |
T36 |
ThemeOf |
ketosis,evaluated |
| R50 |
T33 |
T36 |
ThemeOf |
insulin sensitivity,evaluated |
| R51 |
T35 |
T36 |
ThemeOf |
FGF21,evaluated |
| R52 |
T37 |
T36 |
ThemeOf |
excess,evaluated |
| R53 |
T38 |
T39 |
ThemeOf |
excess,undertook |
| R54 |
T42 |
T39 |
ThemeOf |
bariatric,undertook |
| R55 |
T42 |
T41 |
ThemeOf |
bariatric,underwent |
| R56 |
T44 |
T45 |
ThemeOf |
FGF21,levels |
| R57 |
T44 |
T46 |
ThemeOf |
FGF21,higher |
| R58 |
T45 |
T46 |
ThemeOf |
levels,higher |
| R59 |
T47 |
T46 |
ThemeOf |
excess,higher |
| R60 |
T48 |
T49 |
ThemeOf |
lose,induced |
| R61 |
T50 |
T48 |
CauseOf |
decrease,lose |
| R62 |
T50 |
T49 |
CauseOf |
decrease,induced |
| R63 |
T51 |
T50 |
ThemeOf |
levels,decrease |
| R64 |
T53 |
T50 |
ThemeOf |
FGF21,decrease |
| R65 |
T53 |
T51 |
ThemeOf |
FGF21,levels |
| R66 |
T55 |
T56 |
ThemeOf |
FGF21,levels |
| R67 |
T57 |
T60 |
ThemeOf |
bariatric,showed |
| R68 |
T57 |
T61 |
ThemeOf |
bariatric,increase |
| R69 |
T59 |
T60 |
ThemeOf |
obese,showed |
| R70 |
T59 |
T61 |
ThemeOf |
obese,increase |
| R71 |
T59 |
T64 |
ThemeOf |
obese,higher |
| R72 |
T64 |
T61 |
CauseOf |
higher,increase |
| R73 |
T63 |
T60 |
ThemeOf |
FGF21,showed |
| R74 |
T63 |
T61 |
ThemeOf |
FGF21,increase |
| R75 |
T63 |
T64 |
ThemeOf |
FGF21,higher |
| R76 |
T66 |
T67 |
ThemeOf |
FGF21,changes |
| R77 |
T66 |
T68 |
ThemeOf |
FGF21,occur |
| R78 |
T67 |
T68 |
ThemeOf |
changes,occur |
| R79 |
T70 |
T68 |
ThemeOf |
ketosis,occur |
| R80 |
T70 |
T71 |
ThemeOf |
ketosis,situation |
| R81 |
T70 |
T76 |
ThemeOf |
ketosis,induced |
| R82 |
T72 |
T68 |
ThemeOf |
bariatric,occur |
| R83 |
T72 |
T71 |
ThemeOf |
bariatric,situation |
| R84 |
T72 |
T76 |
ThemeOf |
bariatric,induced |
| R85 |
T73 |
T76 |
ThemeOf |
improvement,induced |
| R86 |
T74 |
T68 |
ThemeOf |
adiposity,occur |
| R87 |
T74 |
T71 |
ThemeOf |
adiposity,situation |
| R88 |
T74 |
T73 |
ThemeOf |
adiposity,improvement |
| R89 |
T74 |
T76 |
ThemeOf |
adiposity,induced |
| R90 |
T75 |
T68 |
ThemeOf |
sensitivity,occur |
| R91 |
T75 |
T71 |
ThemeOf |
sensitivity,situation |
| R92 |
T75 |
T73 |
ThemeOf |
sensitivity,improvement |
| R93 |
T75 |
T76 |
ThemeOf |
sensitivity,induced |
| R94 |
T78 |
T79 |
ThemeOf |
FGF21,levels |
| R95 |
T78 |
T80 |
ThemeOf |
FGF21,reduced |
| R96 |
T79 |
T80 |
ThemeOf |
levels,reduced |
| R97 |
T79 |
T82 |
ThemeOf |
levels,increased |
| R98 |
T81 |
T80 |
CauseOf |
energy-restricted treatments,reduced |
| R99 |
T83 |
T82 |
ThemeOf |
bariatric,increased |
| R100 |
T87 |
T82 |
ThemeOf |
ketosis,increased |
| R101 |
T87 |
T84 |
ThemeOf |
ketosis,reduction |
| R102 |
T89 |
T90 |
ThemeOf |
FGF21,marker |
| R103 |
T89 |
T92 |
ThemeOf |
FGF21,stress |
| R104 |
T91 |
T90 |
ThemeOf |
nutritional,marker |
| R105 |
T90 |
T92 |
ThemeOf |
marker,stress |
| R106 |
T91 |
T92 |
ThemeOf |
nutritional,stress |
